Por: Portland Press Herald Health May 13, 2023
WASHINGTON — U.S. health regulators on Friday approved a new type of drug for women dealing with uncomfortable hot flashes caused by menopause. The Food and Drug Administration approved the once-a-day pill from Astellas Pharma to treat moderate-to-severe symptoms, which can include sweating, flushing and chills. Astellas’ drug, Veozah, uses a new approach, targeting brain connections that help control body temperature. The FDA said the... + full article
Time USA Health June 29, 2023
Being the chief people officer for the biotech giant Genentech was stressful enough, but last year, Cori Davis could tell that something more than just stress was starting to affect her. She kept waking up at night covered in sweat, making it difficult to get a good night’s... + más
‘Millions of women suffering in silence’: Female workers want menopause benefits, so why are they so rare? | MarketWatch
Cannabis Can Help Manage Menopause, Study Suggests | Forbes
MarketWatch USA Business June 07, 2023
“Menopause is a normal life stage in women’s lives, yet there is still a need and opportunity for workplaces to enhance their menopause policies and benefits,” Claire Gill, founder of the National Menopause Foundation, said in a statement. “‘Menopause is a normal... + más
Why are celebrities talking about menopause? Once taboo, the topic moves into mainstream conversation. | MarketWatch
Los Angeles Times USA Opinion June 05, 2023
There are an estimated 55 million women in menopause in the United States today, the majority of whom endure its most debilitating symptoms in silence. It doesn’t have to be so debilitating, and it wouldn’t be if we could end the silence and make even a handful of key policy... + más
Now’s The Time to Bring Up Menopause At Work | Time
ABC News USA Life May 13, 2023
Women have suffered for centuries with hot flashes, one of the , without many treatment options.Now, the U.S. Food and Drug Administration has approved a first-of-its-kind drug, fezolinetant, sold under the brand name Veozah, to treat moderate to severe hot flashes during... + más
FDA approves first-of-its-kind drug to treat hot flashes | ABC7
FDA approves drug called Veozah to treat hot flashes resulting from menopause | CBS News
ABC7 USA World May 13, 2023
, without many treatment options.Now, the U.S. Food and Drug Administration has approved a first-of-its-kind drug, fezolinetant, sold under the brand name Veozah, to treat moderate to severe hot flashes during menopause.The drug, a pill taken once a day, is hormone-free, which... + más
FDA approves first-of-its-kind drug to treat hot flashes | ABC News
MarketWatch USA Business December 17, 2022
Winfrey said that during menopause, she suffered from heart palpitations, listlessness and an inability to focus long enough to read a book, one factor that led her to end Oprah’s Book Club. Gwyneth Paltrow, an actress and the creator of the wellness site Goop, said menopause... + más
Welcome to the Menopause Gold Rush | The New York Times
Forbes USA Life October 24, 2022
Gradual process. Beautiful mature woman touching sweater and having hot flashgetty Around 1.3 million women experience menopause in the United States each year. Although menopause begins between 51 and 52 years old, about 5% of women experience early menopause between 40 and 45... + más
California wildfires threaten nearly all of state's cannabis crops | Newsweek
Bank of Ireland offers workers paid menopause leave | CNN
About iurex | Privacy Policy | Disclaimer |